Sharp John P

CIK 00013428943 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001342894

Recent Transactions

50 trades

Award
PhaseBio Pharmaceuticals Inc
Common Stock
2022-05-20$0.68/sh+6,026→ 65,767 total
Award
PhaseBio Pharmaceuticals Inc
Restricted Stock Unit
2022-02-24+24,750→ 24,750 total
Award
PhaseBio Pharmaceuticals Inc
Employee Stock Option (right to buy)
2022-02-24+115,500→ 115,500 total
Award
PhaseBio Pharmaceuticals Inc
Common Stock
2021-11-19$2.01/sh+2,017→ 59,741 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Common Stock
2021-11-03$1.68/sh+7,500→ 57,724 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Employee Stock Option (right to buy)
2021-11-03$1.68/sh−7,500→ 90,582 total
Award
PhaseBio Pharmaceuticals Inc
Common Stock
2021-08-03$1.68/sh+7,500→ 50,224 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Employee Stock Option (right to buy)
2021-08-03−7,500→ 98,082 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Common Stock
2021-08-03$1.68/sh+7,500→ 50,224 total
Award
PhaseBio Pharmaceuticals Inc
Common Stock
2021-05-20$2.80/sh+1,419→ 42,724 total
Award
PhaseBio Pharmaceuticals Inc
Employee Stock Option (right to buy)
2021-02-05+76,500→ 76,500 total
Award
PhaseBio Pharmaceuticals Inc
Common Stock
2020-11-20$3.00/sh+1,305→ 41,305 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Employee Stock Option (right to buy)
2020-08-14−5,000→ 105,582 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Common Stock
2020-08-14$1.69/sh+5,000→ 40,000 total
Award
PhaseBio Pharmaceuticals Inc
Employee Stock Option (right to buy)
2020-02-12+100,000→ 100,000 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Common Stock
2019-08-21$1.44/sh+5,000→ 35,000 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Employee Stock Option (right to buy)
2019-08-21−5,000→ 4,038 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Common Stock
2019-08-21$1.69/sh+10,000→ 30,000 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Employee Stock Option (right to buy)
2019-08-21−10,000→ 110,582 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Common Stock
2019-05-22$1.69/sh+15,000→ 20,000 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Employee Stock Option (right to buy)
2019-05-22−15,000→ 120,582 total
Award
PhaseBio Pharmaceuticals Inc
Employee Stock Option (right to buy)
2019-02-27+100,000→ 100,000 total
Purchase
PhaseBio Pharmaceuticals Inc
Common Stock
2018-12-07$3.84/sh+5,000→ 5,000 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Non-Qualified Stock Option (right to buy)
2014-02-12−7,495→ 347 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2014-02-12$40.86/sh+8,333→ 26,000 total
Sale
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2014-02-12$75.73/sh−8,333→ 17,667 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2014-02-12$21.00/sh+7,321→ 24,988 total
Sale
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2014-02-12$74.27/sh−7,321→ 17,667 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2014-02-12$21.00/sh+6,012→ 23,679 total
Sale
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2014-02-12$75.73/sh−6,012→ 17,667 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2014-02-12$10.05/sh+6,086→ 23,753 total
Sale
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2014-02-12$74.27/sh−6,086→ 17,667 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2014-02-12$10.05/sh+10,789→ 28,456 total
Sale
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2014-02-12$75.73/sh−10,789→ 17,667 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2014-02-12$14.47/sh+2,879→ 20,546 total
Sale
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2014-02-12$75.73/sh−2,879→ 17,667 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2014-02-12$14.47/sh+14,622→ 32,289 total
Sale
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2014-02-12$74.27/sh−14,622→ 17,667 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2014-02-12$21.92/sh+4,584→ 22,251 total
Sale
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2014-02-12$74.27/sh−4,584→ 17,667 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2014-02-12$9.96/sh+7,495→ 25,162 total
Sale
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2014-02-12$74.27/sh−7,495→ 17,667 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Incentive Stock Option (right to buy)
2014-02-12−10,789→ 13,125 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Incentive Stock Option (right to buy)
2014-02-12−2,879→ 8,917 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Incentive Stock Option (right to buy)
2014-02-12−16,666→ 0 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Incentive Stock Option (right to buy)
2014-02-12−7,321→ 6,012 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Incentive Stock Option (right to buy)
2014-02-12−6,012→ 0 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Incentive Stock Option (right to buy)
2014-02-12−8,333→ 0 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Non-Qualified Stock Option (right to buy)
2014-02-12−6,086→ 0 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Non-Qualified Stock Option (right to buy)
2014-02-12−14,622→ 8,582 total

Companies

Recent Filings

Address

10275 SCIENCE CENTER DRIVE

SAN DIEGO, CA, 92121

View on SEC.gov